Trending Health

Since it was signed into law in 2022, the health industry has been abuzz about the longer-term impact of the Inflation Reduction Act. In this episode, Jen & Mindy sit down to discuss recent headlines and developments around this landmark legislation and what Life Sciences companies should expect over the course of the next year.

For more perspective on the Inflation Reduction Act\’s impact on Life Sciences companies, check out Mindy’s article in Pharmaphorum, "Seizing the moment: The life sciences industry at the threshold of change”.

Podcast Tags: healthcare, healthcare news, life sciences, health policy, inflation reduction act, drug prices, pharmaceutical

Panel – Jen Burke, Mindy McGrath

Research & Production – Jen Burke, Mindy McGrath

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this episode, Mindy, Ryan, and Jen discuss recent newsworthy items, including the ruling by Alabama’s Supreme Court that frozen embryos can be legally regarded as “extrauterine children” under state law, and the impact this decision has had on in vitro fertilization (IVF) procedures. They also cover the release of additional guidance from CMS on the Medicare Prescription Payment Plan and a new report from Reuters that revealed the dramatic increase in new drug prices throughout 2023.

Podcast Tags: healthcare, healthcare news, IVF, embryos, supreme court, reproductive health, life sciences, health policy, inflation reduction act, CMS, medicare, medicaid, drug prices, pharmaceutical

Source Links:

• The science of IVF: What to know about Alabama\’s \’extrauterine children\’ ruling
• Rare Diseases at FDA
• Prices for new US drugs rose 35% in 2023, more than the previous year.

Panel – Jen Burke, Mindy McGrath, Ryan Hummel

Research & Production – Anna Briccetti, Jen Burke

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this episode, Jack, Ollie, and Jen discuss some recent European-based newsworthy items, covering a prominent oncology society\’s push for tumor classification reform that could have profound impacts on cancer survival rates, the critical need for measles vaccination, and Sweden\’s pioneering use of drones in cardiac arrest intervention.

Podcast Tags: healthcare, healthcare news, life sciences, precision oncology, cancer, molecular testing, infectious diseases, vaccination, NHS sustainability, innovation, Sweden

Source Links:

• We’re naming cancers all wrong, oncology leader says
• Forget lung, breast or prostate cancer: why tumour naming needs to change
• Redefining Cancer Classification: A Shift from Organ-based to Molecular-based Approach
• A 30-fold rise of measles cases in 2023 in the WHO European Region warrants urgent action
• Measles in Europe: WHO calls for ‘urgent’ vaccinations as cases surge
• Europe Needs to Get on Top of Its Measles Outbreak
• Europe faces resurgence of measles due to low vaccination coverage
• Europe\’s first transport of blood bags by drone takes place in Belgium
• NHS to pioneer drone deliveries in bid to improve service
• Drone chemotherapy becomes an NHS net zero cancer strategy
• Sweden uses drones to fight cardiac arrest
• Healthcare From Above: Challenges And Opportunities Of Medical Drones
• Flight Trials for Scots Medicine-carrying Drones Conducted
• Government to invest £30 million in innovative technology for NHS
• Department of Health and Social Care: Medical Technology Strategy
• Drones to deliver NHS medication to care homes and GP surgeries in major roll-out
• NHS to begin delivering critical medical supplies by drone

Panel – Jack Young, Jen Burke, Ollie May

Research & Production – Jack Young, Karan Pandya, Ollie May

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at1-888-VYNAMIC.

Over the last few years, the MedTech market has been navigating an unpredictable environment due to macro-economic factors and pandemic-driven activity. As we start off 2024, there’s a prevailing feeling that this market is finally starting to stabilize. In this episode, Jen is joined by Vynamic’s Anila Patel and Head of Health Technology Sector, Mary Virzi, to chat about what MedTech moves we’ve seen so far and what we can expect as 2024 kicks into gear.

Podcast Tags: healthcare, medtech, product launch, medical device, health tech, healthcare technology

Source Links:

• The biggest stories from the 2024 J.P. Morgan Healthcare Conference
• 5 medtech trends to watch in 2024
• MEDTECH AND DIAGNOSTICS MARKET: 2023 TRENDS AND 2024 OUTLOOK
• Medtronic aims to leverage medical device data for AI-enabled care
• 4 heart device trends shaping the medtech sector in 2024
• J&J\’s Biosense Webster puts forward pulsed field ablation data showing no afib after one year
• Boston Scientific nets Farapulse approval, pushes back US TAVR launch
• J&J\’s Biosense Webster puts forward pulsed field ablation data showing no afib after one year
• Medtronic snags first pulsed field ablation approval in US
• Spotlight – J&J takes on Medtronic and Boston in pulsed field ablation
• Increasing diabetes awareness boosts the diabetes care devices market

Panel – Mary Virzi, Anila Patel, Jen Burke

Research & Production – Adrea Cope, Everly Petruzzelli

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this episode, Jen sits down with Vynamic’s Deal Activation & Partnership Enablement Service Leads, Senior Director Kevin Fletcher and Executive Sean Martin, to discuss recent newsworthy items coming out of the J.P. Morgan Healthcare Conference, including the major acquisitions and deals announced, particularly those focused on AI and digital innovation.

Check out Vynamic’s Deal Activation & Partnership Enablement Service page to learn more about how Vynamic helps clients manage critical, time-sensitive activities across the deal life cycle.

Podcast Tags: healthcare, healthcare news, life sciences, pharmaceutical, JP Morgan, deal activation, partnerships, mergers, acquisitions, AI, digital innovation

Source Links:

• Inizio Biotech key takeaways from JPM industry event
• Cigna sells Medicare business to Health Care Service for $3.3 bln
• Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics
• J&J, Merck and Boston Scientific Go on $6.4 Billion Buying Spree
• Amazon rolls out digital health benefits program, taps Omada Health as launch partner
• What the Health Care Sector Was Selling at the J.P. Morgan Confab
• Jefferson Health says LVHN merger would double its insurance business within 2 years

Panel – Jen Burke, Kevin Fletcher, Sean Martin

Research & Production – Anna Briccetti, Jen Burke

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

Within Life Sciences companies, Medical Affairs teams are tasked with gathering and communicating scientific data, a job that has only grown in importance as therapies have grown more complex and stakeholders have multiplied. Stretched in many directions and under high scrutiny, Medical Affairs teams need to be able to effectively measure and communicate the value of their work. In this deep dive episode, Jen is joined by Gemma Pfister, Head of Life Sciences Europe at Vynamic and Lori Klein, Partner, Medical & Scientific Affairs Practice Lead at Putnam, to discuss what leaders should be thinking about when it comes to measuring impact in Medical Affairs.

For more information about the work Putnam does in the Medical Affairs space, visit Putnam’s Medical & Scientific Affairs page. To learn more about Vynamic’s work in Medical Affairs, visit Vynamic’s Medical Affairs page.

Podcast Tags: healthcare, life sciences, medical affairs, omnichannel, AI

Panel – Gemma Pfister, Jen Burke, Lori Klein

Research & Production – Jen Burke

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this episode, Jack, Ollie, and Jen discuss some recent European-based newsworthy items, including the potential impact of Wegovy in reducing excess deaths in the UK, a groundbreaking report on minimising the environmental footprint of surgical care, and Lithuania\’sinnovation wave in biotech and MedTech.

Podcast Tags: healthcare, healthcare news, life sciences, obesity, medtech, sustainability, biotech, medtech, innovation, lithuania

Source Links:

• Excess mortality in England post COVID-19 pandemic: implications for secondary prevention
• UK life expectancy falls to lowest level in a decade
• Excess deaths involving cardiovascular disease: an analysis
• Wegovy made available in the uk for weight loss in people with prediabetes and type 2 diabetes
• Our response to serious supply issues of drugs for people with type 2 diabetes
• Ministers launch £40m pilot scheme to trial wider access to slimming jab
• Health Inequalities, Lives, Cut Short, January 2024
• Can Denmark\’s world-beating drugs maker stay ahead?
• Landmark report on reducing environmental impact of surgical care published
• Green Surgery – Reducing the environmental impact of surgical care
• Lithuania Set to Become Home to Largest Biotech City
• Northway Group to build $7.6bn ‘biotech city’ in Lithuania
• Baltic-bound: is Lithuania desirable for EU life science investment?

Panel –Jack Young, Jen Burke, Ollie May

Research & Production – Jack Young, Karan Pandya, Ollie May

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at1-888-VYNAMIC.

The US Pharmacy Industry is the largest in the world, with many different players involved in ensuring pharmaceutical products reach consumers. These channels and distribution outlets have drastically changed over the years and will only continue to evolve. The pharmacy channel has reimagined how they are reaching patients, managing risks, and deriving value, expanding their business models beyond dispensing prescription drugs to become wellness destinations. Mindy and Jen are joined by Health Services Heads of Sector, Saurabh Raman and Ryan Hummel, to discuss this complex industry and its evolution.

For more information about the work discussed in this episode, check out https://vynamic.com/what-we-do/health-industry/health-services/

Podcast Tags: healthcare, mergers & acquisitions, pharmacy, PBMs, pharmacists, specialty pharmacy, health services

Source Links:

• Market Insights: Pharmacies–Worldwide
• 7 surprising facts about the pharmaceutical industry
• The Impact of Pharmaceutical Wholesalers on U.S. Drug Spending
• Pharmacy Benefit Managers: Practices, Controversies, and What Lies Ahead
• Competition, Consolidation, and Evolution in the Pharmacy Market
• CVS Pharmacy Downsizes: 10 Industry Trends Driving the Retail Shakeout
• 2023 Forecast: Pharmacists push to take on a greater role in patient care
• A new day in retail pharmacy: The evolving role of pharmacist
• Five Trends Transforming Pharmacies into Wellness Centers of the Future
• Community Pharmacists’ Contributions to Disease Management During the COVID-19 Pandemic
• An Inside Look at Walgreens\’ primary care and pharmacy model
• CVS Health completes acquisition of Oak Street Health
• CVS launches new venture in biosimilar drug experiment
• AMA: Don\’t expand scope of practice for already overworked pharmacists

Panel – Jen Burke, Mindy McGrath, Ryan Hummel, Saurabh Raman

Research & Production – Adrea Cope, Everly Petruzzelli, Jen Burke

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this episode, Mindy, Ryan, and Jen discuss recent newsworthy items, including the announcement that Bristol Myers Squibb is purchasing RayzeBio, the use of artificial intelligence in discovering antibiotics that stop MRSA infections, and recent reports revealing an increase in medical errors at hospitals owned by private equity firms.

Podcast Tags: healthcare, healthcare news, life sciences, mergers & acquisitions, radiopharma, medtech, artificial intelligence, antibiotics, health services, providers, private equity, hospitals

Source Links:

• BMS enters radiopharma race with $4.1B acquisition of RayzeBio just 3 months after biotech went public
• ‘Explainable’ AI discovers new class of antibiotics that stop MRSA in mice
• Discovery of a structural class of antibiotics with explainable deep learning
• Serious Medical Errors Rose After Private Equity Firms Bought Hospitals

Panel – Jen Burke, Mindy McGrath, Ryan Hummel

Research & Production – Anna Briccetti, Jen Burke

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this special episode, we conclude our annual series on the biggest health industry trends of the next year. Jen sits down with Vynamic Senior Executives Karen Baldry, Mindy McGrath, and Ryan Hummel, and Executives Mary Virzi and Saurabh Raman to discuss the five trends they expect to be most impactful in 2024. These trends include 1) policy implications & judicial decisions, 2) realizing the value of convergence, 3) healthcare as a service, 4) revolutionizing healthcare through AI tech, and 5) next-gen meds.

To learn more about Vynamic’s 2024 health industry outlook, visit https://vynamic.com/insights/2024-health-industry-outlook/

Podcast Tags: healthcare, healthcare news, healthcare trends

Panel – Jen Burke, Karen Baldry, Mary Virzi, Mindy McGrath, Ryan Hummel, Saurabh Raman

Research & Production – Jen Burke, Mindy McGrath

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.